Schedule 13G ownership disclosure

BIOCRYST PHARMACEUTICALS INC

Security class unavailable · CUSIP: 09058V103

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,898,615
Percent of class
6.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000215457-16-002121
Form type
SC 13G/A
Filer
BIOCRYST PHARMACEUTICALS INC
CIK
CIK 882796
Filed
Jan 25, 2016
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub